Search Knowledge Base

6 results for "hypophosphatemia"

Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic Review pubmed_article
Evidence Source 2025 PMID: 39935027
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials pubmed_article
Evidence Source 2020 PMID: 32016310
Comparative Risk of Hypophosphatemia Following the Administration of Intravenous Iron Formulations: A Network Meta-Analysis pubmed_article
Evidence Source 2020 PMID: 32819760
X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline. unknown
wiki/sources/guideline-pmid-39960858
X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline. unknown
wiki/sources/guideline-pmid-40243526
Experts' consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan. unknown
wiki/sources/guideline-pmid-40591205

Evidence Search Results semantic · quality-ranked

Comparative Risk of Hypophosphatemia Following the Administration of Intravenous Iron Formulations: A Network Meta-Analysis systematic_review pubmed_article
Quality: 64 2020 PMID: 32819760 DOI: 10.1016/j.tmrv.2020.07.002
Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic Review systematic_review pubmed_article
Quality: 51 2025 PMID: 39935027 DOI: 10.1002/ajh.27598
Experts' consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan. guideline guideline
Quality: 65 2025 PMID: 40591205 DOI: 10.1007/s40618-025-02611-7
X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline. guideline guideline
Quality: 73 2025 PMID: 39960858 DOI: 10.1210/clinem/dgaf093
X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline. guideline guideline
Quality: 73 2025 PMID: 40243526 DOI: 10.1210/clinem/dgaf170
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials rct pubmed_article
Quality: 70 2020 PMID: 32016310 DOI: 10.1001/jama.2019.22450
IMPORTANCE: Intravenous iron enables rapid correction of iron-deficiency anemia, but certain formulations induce fibroblast growth factor 23-mediated hypophosphatemia. OBJECTIVE: To compare risks of h...
Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials meta_analysis pubmed_article
Quality: 67 2022 PMID: 34775773 DOI: 10.21037/apm-21-1943
The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials meta_analysis pubmed_article
Quality: 65 2022 PMID: 34061337 DOI: 10.1007/s40620-021-01065-3
Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports systematic_review pubmed_article
Quality: 52 2022 PMID: 35426179 DOI: 10.1002/jbmr.4558
The Association Between the Concentration of Serum Magnesium and Postmenopausal Osteoporosis systematic_review pubmed_article
Quality: 55 2020 PMID: 32850896 DOI: 10.3389/fmed.2020.00381

View full evidence search →